UK HealthCare logo
malluche-hartmut

Hartmut H. Malluche, MD

Chief, Division of Nephrology, Bone and Mineral Metabolism
Medical Director, Bone Diagnostic and Research Laboratory

Practice areas

  • Nephrology, Bone & Mineral Metabolism

Faculty rank

Professor of Medicine

Clinic information

Clinical interests

  • Bone and Mineral Abnormalities in Chronic Kidney Diseases
  • Nephrology
  • Osteoporosis
  • Paget's Bone Disease
  • Renal Diseases

Education

Degree

Johann Wolfgang Goethe Universitat, Frankfurt Am Main, Germany

Residency

Johann Wolfgang Goethe Universitat, Frankfurt Am Main, Germany

Fellowship

Johann Wolfgang Goethe Universitat, Frankfurt Am Main, Germany

Additional information

Profile
My name is Harmut Malluche; I received my medical degree and completed a fellowship at Johann Wolfgang Goethe Universitat, Frankfurt Am Main, Germany.

Research/Publications

  1. Ok E, Asci G, Bayraktaroglu S, Toz H, Ozkahya M, Yilmaz M, Kircelli F, Sevinc Ok E, Ceylan N, Duman S, Cirit M, Monier-Faugere MC, Malluche HH. Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol. 2016 Aug;27(8):2475-86.
    View in: PubMed
  2. Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. Am J Kidney Dis. 2016 Apr;67(4):559-66.
    View in: PubMed
  3. Sugatani T, Agapova O, Malluche HH, Hruska KA. SIRT6 deficiency culminates in low-turnover osteopenia. Bone. 2015 Dec;81:168-77. PubMed
  4. Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL. High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. J Am Soc Nephrol. 2015 Oct;26(10):2534-44.
    View in: PubMed
  5. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013 Jan; 28(1):2-17. PMID: 23197339.
    View in: PubMed
  6. Malluche HH, Porter DS, Monier-Faugere MC, Mawad H, Pienkowski D. Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol. 2012 Mar; 23(3):525-32. PMID: 22193385.
    View in: PubMed
  7. Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011 Jun; 26(6):1368-76. PMID: 21611975.
    View in: PubMed
  8. Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D, Haas M, Malluche HH. Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol. 2011 Apr; 6(4):877-82. PMID: 21164019.
    View in: PubMed
  9. O'Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int. 2011 Mar; 79(5):512-7. PMID: 21124302.
    View in: PubMed
  10. London G, Coyne D, Hruska K, Malluche HH, Martin KJ. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol. 2010 Dec; 74(6):423-32. PMID: 21084045.
    View in: PubMed
  11. Asci G, Ok E, Savas R, Ozkahya M, Duman S, Toz H, Kayikcioglu M, Branscum AJ, Monier-Faugere MC, Herberth J, Malluche HH. The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transplant. 2011 Mar; 26(3):1010-5. PMID: 20709740.
    View in: PubMed
  12. Koszewski NJ, Herberth J, Malluche HH. Retinoic acid receptor gamma 2 interactions with vitamin D response elements. J Steroid Biochem Mol Biol. 2010 Jun; 120(4-5):200-7. PMID: 20420906.
    View in: PubMed
  13. Herberth J, Branscum AJ, Mawad H, Cantor T, Monier-Faugere MC, Malluche HH. Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study. Am J Kidney Dis. 2010 May; 55(5):897-906. PMID: 20347512.
    View in: PubMed
  14. Malluche HH, Monier-Faugere MC, Herberth J. Bone disease after renal transplantation. Nat Rev Nephrol. 2010 Jan; 6(1):32-40. PMID: 19918255.
    View in: PubMed
  15. Moore C, Yee J, Malluche H, Rao DS, Monier-Faugere MC, Adams E, Daramola-Ogunwuyi O, Fehmi H, Bhat S, Osman-Malik Y. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol. 2009 Sep; 4(9):1484-1493. PMID: 19713297.
    View in: PubMed
  16. Malluche HH, Sawaya BP. Tempora mutantur et nos mutamur in illis - Times are changing, and so are we. Clin Nephrol. 2009 Jul; 72(1):3-4. PMID: 19640381.
    View in: PubMed
  17. Herberth J, Monier-Faugere MC, Mawad HW, Branscum AJ, Herberth Z, Wang G, Cantor T, Malluche HH. The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients. Clin Nephrol. 2009 Jul; 72(1):5-14. PMID: 19640382.
    View in: PubMed
  18. Adragao T, Herberth J, Monier-Faugere MC, Branscum AJ, Ferreira A, Frazao JM, Malluche HH. Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients. Osteoporos Int. 2010 Apr; 21(4):619-25. PMID: 19554246.
    View in: PubMed
  19. Fehmi H, Osman Y, Bhat S, Nguyen K, Daramola O, Cantor T, Monier-Faugere MC, Yee J, Malluche HH. Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio. Clin Nephrol. 2009 Mar; 71(3):267-75. PMID: 19281737.
    View in: PubMed
  20. Adragao T, Herberth J, Monier-Faugere MC, Branscum AJ, Ferreira A, Frazao JM, Dias Curto J, Malluche HH. Low bone volume--a risk factor for coronary calcifications in hemodialysis patients. Clin J Am Soc Nephrol. 2009 Feb; 4(2):450-5. PMID: 19158372.
    View in: PubMed
  21. Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O'Neill WC. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int. 2009 Mar; 75(6):617-25. PMID: 19129793.
    View in: PubMed
  22. Fahrleitner-Pammer A, Herberth J, Browning SR, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche HH. Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res. 2008 Nov; 23(11):1850-8. PMID: 18597636.
    View in: PubMed
  23. Malluche HH, Mawad H, Monier-Faugere MC. Effects of treatment of renal osteodystrophy on bone histology. Clin J Am Soc Nephrol. 2008 Nov; 3 Suppl 3:S157-63. PMID: 18988701.
    View in: PubMed
  24. Malluche HH, Siami GA, Swanepoel C, Wang GH, Mawad H, Confer S, Smith M, Pratt RD, Monier-Faugere MC. Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years. Clin Nephrol. 2008 Oct; 70(4):284-95. PMID: 18826853.
    View in: PubMed
  25. Malluche HH, Monier-Faugere MC, Wang G, Frazã O JM, Charytan C, Coburn JW, Coyne DW, Kaplan MR, Baker N, McCary LC, Turner SA, Goodman WG. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol. 2008 Apr; 69(4):269-78. PMID: 18397701.
    View in: PubMed
  26. Nieminen J, Sahlman J, Hirvonen T, Lapveteläinen T, Miettinen M, Arnala I, Malluche HH, Helminen HJ. Disturbed synthesis of type II collagen interferes with rate of bone formation and growth and increases bone resorption in transgenic mice. Calcif Tissue Int. 2008 Mar; 82(3):229-37. PMID: 18297226.
    View in: PubMed
  27. Herberth J, Alimov AP, Williams JP, Malluche HH, Koszewski NJ. PTH regulation of the human cytomegalovirus immediate-early gene promoter. Biochem Biophys Res Commun. 2008 Apr 18; 368(4):977-82. PMID: 18279669.
    View in: PubMed
  28. Ferreira A, Frazão JM, Monier-Faugere MC, Gil C, Galvao J, Oliveira C, Baldaia J, Rodrigues I, Santos C, Ribeiro S, Hoenger RM, Duggal A, Malluche HH. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol. 2008 Feb; 19(2):405-12. PMID: 18199805.
    View in: PubMed
  29. Malluche HH, Mawad H, Monier-Faugere MC. Bone biopsy in patients with osteoporosis. Curr Osteoporos Rep. 2007 Dec; 5(4):146-52. PMID: 18430388.
    View in: PubMed
  30. Monier-Faugere MC, Mawad H, Malluche HH. Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1255-60. PMID: 17942766.
    View in: PubMed
  31. Lin YL, de Villiers WJ, Garvy B, Post SR, Nagy TR, Safadi FF, Faugere MC, Wang G, Malluche HH, Williams JP. The effect of class a scavenger receptor deficiency in bone. J Biol Chem. 2007 Feb 16; 282(7):4653-60. PMID: 17166840.
    View in: PubMed
  32. Malluche HH, Koszewski N, Monier-Faugere MC, Williams JP, Mawad H. Influence of the parathyroid glands on bone metabolism. Eur J Clin Invest. 2006 Aug; 36 Suppl 2:23-33. PMID: 16884395.
    View in: PubMed
  33. Herberth J, Fahrleitner-Pammer A, Obermayer-Pietsch B, Krisper P, Holzer H, Malluche HH, Dobnig H. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease. Clin Nephrol. 2006 May; 65(5):328-34. PMID: 16724653.
    View in: PubMed
  34. Malluche HH, Monier-Faugere MC. Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings. Clin Nephrol. 2006 Apr; 65(4):235-42. PMID: 16629221.
    View in: PubMed
  35. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology. 2005 Aug; 146(8):3622-31. PMID: 15905321.
    View in: PubMed
  36. Alimov AP, Park-Sarge OK, Sarge KD, Malluche HH, Koszewski NJ. Transactivation of the parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex. Endocrinology. 2005 Aug; 146(8):3409-16. PMID: 15890770.
    View in: PubMed
  37. Freemont T, Malluche HH. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. Clin Nephrol. 2005 Feb; 63(2):138-45. PMID: 15730056.
    View in: PubMed
  38. Koszewski NJ, Alimov AP, Langub MC, Park-Sarge OK, Malluche HH. Contrasting mammalian PTH promoters: identification of transcription factors controlling PTH gene expression. Clin Nephrol. 2005 Feb; 63(2):158-62. PMID: 15730058.
    View in: PubMed
  39. Koszewski NJ, Alimov AP, Park-Sarge OK, Malluche HH. Suppression of the human parathyroid hormone promoter by vitamin D involves displacement of NF-Y binding to the vitamin D response element. J Biol Chem. 2004 Oct 8; 279(41):42431-7. PMID: 15297458.
    View in: PubMed
  40. Alimov AP, Langub MC, Malluche HH, Park-Sarge OK, Koszewski NJ. Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer. Endocrinology. 2004 Jun; 145(6):2713-20. PMID: 15001549.
    View in: PubMed
  41. Malluche HH, Mawad H, Monier-Faugere MC. The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? Nephrol Dial Transplant. 2004 Mar; 19 Suppl 1:i9-13. PMID: 15126648.
    View in: PubMed
  42. Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis. 2004 Mar; 43(3):558-65. PMID: 14981615.
    View in: PubMed
  43. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P, Tellis V, Greenstein S, Schechner R, Figueroa K, McDonough P, Wang G, Malluche H. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol. 2003 Oct; 14(10):2669-76. PMID: 14514747.
    View in: PubMed
  44. Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC, Malluche HH. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int. 2003 Aug; 64(2):737-42. PMID: 12846773.
    View in: PubMed
  45. Trueba D, Sawaya BP, Mawad H, Malluche HH. Bone biopsy: indications, techniques, and complications. Semin Dial. 2003 Jul-Aug; 16(4):341-5. PMID: 12926408.
    View in: PubMed
  46. Alimov AP, Langub MC, Malluche HH, Koszewski NJ. Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter. Endocrinology. 2003 Jul; 144(7):3138-47. PMID: 12810570.
    View in: PubMed
  47. Malluche HH, Mawad H, Trueba D, Monier-Faugere MC. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients. Clin Nephrol. 2003 May; 59(5):313-8. PMID: 12779091.
    View in: PubMed
  48. Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res. 2003 May; 18(5):836-43. PMID: 12733722.
    View in: PubMed
  49. Malluche HH, Monier-Faugere MC. Pth 1-84, Pth fragments and bone turnover. Am J Kidney Dis. 2003 May; 41(5):1127. PMID: 12722056.
    View in: PubMed
  50. Langub MC, Monier-Faugere MC, Wang G, Williams JP, Koszewski NJ, Malluche HH. Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. Endocrinology. 2003 Apr; 144(4):1135-8. PMID: 12639892.
    View in: PubMed
  51. Langub MC, Malluche HH. Parathyroid hormone type 1 receptor and human osteoclasts. J Bone Miner Res. 2002 Oct; 17(10):1916. PMID: 12369796.
    View in: PubMed
  52. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002 Nov 15; 277(46):44005-12. PMID: 12215457.
    View in: PubMed
  53. Malluche HH, Mawad H, Koszewski NJ. Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure. Kidney Int. 2002 Aug; 62(2):367-74. PMID: 12109997.
    View in: PubMed
  54. Malluche HH, Mawad H. Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions. Nephrol Dial Transplant. 2002 Jul; 17(7):1170-5. PMID: 12105237.
    View in: PubMed
  55. Malluche HH, Kubodera N. [Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease]. Clin Calcium. 2002 Jun; 12(6):724-9. PMID: 15775357.
    View in: PubMed
  56. Malluche HH, Monier-Faugere MC, Koszewski NJ. Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. Nephrol Dial Transplant. 2002; 17 Suppl 10:6-9. PMID: 12386263.
    View in: PubMed
  57. Malluche HH. Aluminium and bone disease in chronic renal failure. Nephrol Dial Transplant. 2002; 17 Suppl 2:21-4. PMID: 11904354.
    View in: PubMed
  58. Kimmel PL, Langman CB, Bognar B, Faugere MC, Chawla LS, Watkins DW, Malluche HH. Zinc nutritional status modifies renal osteodystrophy in uremic rats. Clin Nephrol. 2001 Dec; 56(6):445-58. PMID: 11770796.
    View in: PubMed
  59. Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int. 2001 Oct; 60(4):1460-8. PMID: 11576360.
    View in: PubMed
  60. Koszewski NJ, Kiessling S, Malluche HH. Isolation of genomic DNA sequences that bind vitamin D receptor complexes. Biochem Biophys Res Commun. 2001 Apr 27; 283(1):188-94. PMID: 11322787.
    View in: PubMed
  61. Ashman N, Malluche HH, Cunningham J. Hypercalcemia and human nature. Clin Nephrol. 2001 Apr; 55(4):327-30. PMID: 11334321.
    View in: PubMed
  62. Langub MC, Monier-Faugere MC, Qi Q, Geng Z, Koszewski NJ, Malluche HH. Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor in human bone. J Bone Miner Res. 2001 Mar; 16(3):448-56. PMID: 11277262.
    View in: PubMed
  63. Langub MC, Herman JP, Malluche HH, Koszewski NJ. Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience. 2001; 104(1):49-56. PMID: 11311530.
    View in: PubMed
  64. Malluche HH, Monier-Faugère MC. Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow. Clin Nephrol. 2000 Oct; 54(4):309-17. PMID: 11076107.
    View in: PubMed
  65. Langub MC, Reinhardt TA, Horst RL, Malluche HH, Koszewski NJ. Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone. 2000 Sep; 27(3):383-7. PMID: 10962349.
    View in: PubMed
  66. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology. 2000 Jul; 141(7):2674-82. PMID: 10875273.
    View in: PubMed
  67. Langub MC, Faugere MC, Malluche HH. Molecular bone morphometry. Pediatr Nephrol. 2000 Jul; 14(7):629-35. PMID: 10912532.
    View in: PubMed
  68. Geng Z, Monier-Faugere MC, Bauss F, Malluche HH. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure. Clin Nephrol. 2000 Jul; 54(1):45-53. PMID: 10939756.
    View in: PubMed
  69. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol. 2000 Jun; 11(6):1093-9. PMID: 10820173.
    View in: PubMed
  70. Koszewski NJ, Malluche HH, Russell J. Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison. J Steroid Biochem Mol Biol. 2000 Mar; 72(3-4):125-32. PMID: 10775803.
    View in: PubMed
  71. Malluche HH, Langub MC, Monier-Faugere MC. The role of bone biopsy in clinical practice and research. Kidney Int Suppl. 1999 Dec; 73:S20-5. PMID: 10633459.
    View in: PubMed
  72. Malluche HH, Monier-Faugere MC. Understanding and managing hyperphosphatemia in patients with chronic renal disease. Clin Nephrol. 1999 Nov; 52(5):267-77. PMID: 10584989.
    View in: PubMed
  73. Monier-Faugere MC, Geng Z, Paschalis EP, Qi Q, Arnala I, Bauss F, Boskey AL, Malluche HH. Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties. J Bone Miner Res. 1999 Oct; 14(10):1768-78. PMID: 10491225.
    View in: PubMed
  74. Mawad HW, Sawaya BP, Sarin R, Malluche HH. Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol. 1999 Sep; 52(3):160-6. PMID: 10499311.
    View in: PubMed
  75. Monier-Faugere MC, Geng Z, Friedler RM, Qi Q, Kubodera N, Slatopolsky E, Malluche HH. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure. Kidney Int. 1999 Mar; 55(3):821-32. PMID: 10027919.
    View in: PubMed
  76. Koszewski NJ, Reinhardt TA, Langub MC, Malluche HH, Horst RL. Selectivity of a C-terminal peptide antiserum for different DNA-binding states of the vitamin D receptor. Arch Biochem Biophys. 1998 Jan 15; 349(2):388-96. PMID: 9448730.
    View in: PubMed
  77. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int. 1998; 8(3):274-81. PMID: 9797913.
    View in: PubMed
  78. Pienkowski D, Doers TM, Monier-Faugere MC, Geng Z, Camacho NP, Boskey AL, Malluche HH. Calcitonin alters bone quality in beagle dogs. J Bone Miner Res. 1997 Nov; 12(11):1936-43. PMID: 9383698.
    View in: PubMed
  79. Fanti P, Monier-Faugere MC, Geng Z, Cohen D, Malluche HH. Moderately high consumption of ethanol suppresses bone resorption in ovariectomized but not in sexually intact adult female rats. Alcohol Clin Exp Res. 1997 Sep; 21(6):1150-4. PMID: 9309330.
    View in: PubMed
  80. Monier-Faugere MC, Malluche HH. Role of cytokines in renal osteodystrophy. Curr Opin Nephrol Hypertens. 1997 Jul; 6(4):327-32. PMID: 9263681.
    View in: PubMed
  81. Szejnfeld VL, Monier-Faugere MC, Bognar BJ, Ferraz MB, Malluche HH. Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis. J Rheumatol. 1997 Apr; 24(4):683-8. PMID: 9101502.
    View in: PubMed
  82. Sawaya BP, Koszewski NJ, Qi Q, Langub MC, Monier-Faugere MC, Malluche HH. Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure. J Am Soc Nephrol. 1997 Feb; 8(2):271-8. PMID: 9048346.
    View in: PubMed
  83. Malluche HH, Langub MC, Monier-Faugere MC. Pathogenesis and histology of renal osteodystrophy. Osteoporos Int. 1997; 7 Suppl 3:S184-7. PMID: 9536329.
    View in: PubMed
  84. Langub MC, Koszewski NJ, Turner HV, Monier-Faugere MC, Geng Z, Malluche HH. Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. Kidney Int. 1996 Aug; 50(2):515-20. PMID: 8840280.
    View in: PubMed
  85. Monier-Faugere MC, Geng Z, Qi Q, Arnala I, Malluche HH. Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs. J Bone Miner Res. 1996 Apr; 11(4):446-55. PMID: 8992875.
    View in: PubMed
  86. Liu SM, Koszewski N, Lupez M, Malluche HH, Olivera A, Russell J. Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor. Mol Endocrinol. 1996 Feb; 10(2):206-15. PMID: 8825560.
    View in: PubMed
  87. Monier-Faugere MC, Malluche HH. Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients. Nephrol Dial Transplant. 1996; 11 Suppl 3:111-20. PMID: 8840325.
    View in: PubMed
  88. Malluche HH. Renal bone disease--an ongoing challenge to the nephrologist. Clin Nephrol. 1995 Nov; 44 Suppl 1:S38-41. PMID: 8608661.
    View in: PubMed
  89. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis. 1995 Oct; 26(4):622-31. PMID: 7573017.
    View in: PubMed
  90. Malluche HH, Sawaya BP, Faugere MC. Dialysis: current status, contemporary limitations and future challenges. Kidney Int Suppl. 1995 Aug; 50:S37-9. PMID: 8544434.
    View in: PubMed
  91. Briner VA, Thiel G, Monier-Faugere MC, Bognar B, Landmann J, Kamber V, Malluche HH. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation. 1995 May 27; 59(10):1393-400. PMID: 7770924.
    View in: PubMed
  92. Monier-Faugere MC, Malluche HH. Calcitriol pulse therapy in patients with end-stage renal failure. Curr Opin Nephrol Hypertens. 1994 Nov; 3(6):615-9. PMID: 7881985.
    View in: PubMed
  93. Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 1994 Sep; 46(3):855-61. PMID: 7996807.
    View in: PubMed
  94. Malluche HH, Monier-Faugere MC. The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol. 1994 Mar; 4(9):1631-42. PMID: 8011971.
    View in: PubMed
  95. Monier-Faugere MC, Friedler RM, Bauss F, Malluche HH. A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs. J Bone Miner Res. 1993 Nov; 8(11):1345-55. PMID: 8266826.
    View in: PubMed
  96. McMurtry CT, Godschalk M, Malluche HH, Geng Z, Adler RA. Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature. J Am Geriatr Soc. 1993 Sep; 41(9):983-5. PMID: 8409185.
    View in: PubMed
  97. Colombo G, Fanti P, Yao C, Malluche HH. Isolation and complete amino acid sequence of osteocalcin from canine bone. J Bone Miner Res. 1993 Jun; 8(6):733-43. PMID: 8101026.
    View in: PubMed
  98. Agarwal S, Goodman NL, Malluche HH. Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1993 Jun; 21(6):673-5. PMID: 8503424.
    View in: PubMed
  99. Fanti P, Colombo G, Yao C, Brown SA, Vernon MW, Malluche HH. Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin. J Bone Miner Res. 1993 Jun; 8(6):745-52. PMID: 8328316.
    View in: PubMed
  100. Metsger DS, Arnala I, Faugere MC, Malluche HH. Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeys. Bone. 1993 May-Jun; 14(3):243-8. PMID: 8363863.
    View in: PubMed
  101. Rodgers JB, Monier-Faugere MC, Malluche H. Animal models for the study of bone loss after cessation of ovarian function. Bone. 1993 May-Jun; 14(3):369-77. PMID: 8363880.
    View in: PubMed
  102. Dorr LD, Faugere MC, Mackel AM, Gruen TA, Bognar B, Malluche HH. Structural and cellular assessment of bone quality of proximal femur. Bone. 1993 May-Jun; 14(3):231-42. PMID: 8363862.
    View in: PubMed
  103. Tsukamoto Y, Mariyo R, Nomura Y, Sato N, Faugere MC, Malluche HH. Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients. Bone. 1993 May-Jun; 14(3):421-5. PMID: 8363887.
    View in: PubMed
  104. Fanti P, Kindy MS, Mohapatra S, Klein J, Colombo G, Malluche HH. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. Am J Physiol. 1992 Dec; 263(6 Pt 1):E1113-8. PMID: 1476184.
    View in: PubMed
  105. Malluche HH, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl. 1992 Oct; 38:S62-7. PMID: 1405383.
    View in: PubMed
  106. Malluche HH. The possible use of bisphosphonates in the treatment of renal osteodystrophy. Clin Nephrol. 1992; 38 Suppl 1:S87-91. PMID: 1295713.
    View in: PubMed
  107. Malluche HH, Monier-Faugere MC. Uremic bone disease: current knowledge, controversial issues, and new horizons. Miner Electrolyte Metab. 1991; 17(4):281-96. PMID: 1813791.
    View in: PubMed
  108. Malluche HH. Bone disease in renal failure. Introduction. Miner Electrolyte Metab. 1991; 17(4):209-10. PMID: 1813782.
    View in: PubMed
  109. Freundlich M, Zilleruelo G, Strauss J, Abitbol C, Malluche HH. More on aluminum toxic effects in children with uremia. J Pediatr. 1990 Dec; 117(6):1007-9. PMID: 2246681.
    View in: PubMed
  110. Dorr LD, Arnala I, Faugere MC, Malluche HH. Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone disease. Clin Orthop Relat Res. 1990 Oct; (259):114-21. PMID: 2208845.
    View in: PubMed
  111. Malluche HH, Faugere MC. Effects of 1,25(OH)2D3 administration on bone in patients with renal failure. Kidney Int Suppl. 1990 Sep; 29:S48-53. PMID: 2214547.
    View in: PubMed
  112. Malluche H, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int. 1990 Aug; 38(2):193-211. PMID: 2205749.
    View in: PubMed
  113. Letton RW, Fanti P, Malluche HH. Regulation of 25-hydroxyvitamin D3 metabolism in cultures of osteoblastic cells. J Bone Miner Res. 1990 Aug; 5(8):815-23. PMID: 2173357.
    View in: PubMed
  114. Malluche HH, Faugere MC. Role of calcitriol in the management of osteoporosis. Metabolism. 1990 Apr; 39(4 Suppl 1):24-6. PMID: 2325567.
    View in: PubMed
  115. Faugere MC, Friedler RM, Fanti P, Malluche HH. Bone changes occurring early after cessation of ovarian function in beagle dogs: a histomorphometric study employing sequential biopsies. J Bone Miner Res. 1990 Mar; 5(3):263-72. PMID: 2333786.
    View in: PubMed
  116. Joyce JM, Malluche HH, Coon JS, Ryo UY. Bone densitometry of osteopetrosis in an adolescent girl. Clin Nucl Med. 1990 Jan; 15(1):48-9. PMID: 2306898.
    View in: PubMed
  117. Baker LR, Abrams SM, Roe CJ, Faugere MC, Fanti P, Subayti Y, Malluche HH. Early therapy of renal bone disease with calcitriol: a prospective double-blind study. Kidney Int Suppl. 1989 Nov; 27:S140-2. PMID: 2699994.
    View in: PubMed
  118. Bia MJ, Cooper K, Schnall S, Duffy T, Hendler E, Malluche H, Solomon L. Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int. 1989 Nov; 36(5):852-8. PMID: 2615192.
    View in: PubMed
  119. Malluche HH, Faugere MC. Renal osteodystrophy. N Engl J Med. 1989 Aug 3; 321(5):317-9. PMID: 2747771.
    View in: PubMed
  120. Baker LR, Abrams L, Roe CJ, Faugere MC, Fanti P, Subayti Y, Malluche HH. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989 Feb; 35(2):661-9. PMID: 2651758.
    View in: PubMed
  121. Dunlay RW, Camp MA, Allon M, Fanti P, Malluche HH, Llach F. Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome. Ann Intern Med. 1989 Jan 15; 110(2):162-4. PMID: 2909207.
    View in: PubMed
  122. Malluche HH, Faugere MC, Friedler RM, Fanti P. 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. Endocrinology. 1988 May; 122(5):1998-2006. PMID: 3359973.
    View in: PubMed
  123. Malluche HH, Faugere MC. Aluminum-related bone disease. Blood Purif. 1988; 6(1):1-15. PMID: 3345241.
    View in: PubMed
  124. Malluche HH, Arnala I, Faugere MC. Values of noninvasive techniques in predicting bone histology. Ann Chir Gynaecol. 1988; 77(5-6):246-50. PMID: 3267106.
    View in: PubMed
  125. Abreo K, Malluche HH. Effect of 1,25-vitamin D and parathyroidectomy on the uptake of aluminum in bone of rats with renal insufficiency. Am J Nephrol. 1988; 8(5):426-30. PMID: 3239602.
    View in: PubMed
  126. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987 Dec; 2(6):595-610. PMID: 3455637.
    View in: PubMed
  127. Julian BA, Faugere MC, Malluche HH. Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy. Am J Kidney Dis. 1987 May; 9(5):436-40. PMID: 2437794.
    View in: PubMed
  128. Malluche HH, Faugere MC, Friedler RM, Matthews C, Fanti P. Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. J Clin Invest. 1987 Mar; 79(3):754-61. PMID: 3818947.
    View in: PubMed
  129. Malluche HH, Faugere MC, Rush M, Friedler R. Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental beagle dogs. Endocrinology. 1986 Dec; 119(6):2649-54. PMID: 3780545.
    View in: PubMed
  130. Faugere MC, Malluche HH. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int. 1986 Nov; 30(5):717-22. PMID: 2431192.
    View in: PubMed
  131. Malluche HH, Matthews C, Faugere MC, Fanti P, Endres DB, Friedler RM. 1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology. 1986 Sep; 119(3):1298-304. PMID: 3755395.
    View in: PubMed
  132. Freundlich M, Zilleruelo G, Faugere MC, Abitbol C, Strauss J, Malluche HH. Treatment of aluminum toxicity in infantile uremia with deferoxamine. J Pediatr. 1986 Jul; 109(1):140-3. PMID: 3723235.
    View in: PubMed
  133. Faugere MC, Arnala IO, Ritz E, Malluche HH. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. J Lab Clin Med. 1986 Jun; 107(6):481-7. PMID: 3486929.
    View in: PubMed
  134. Fanti P, Smith AJ, Price PA, Reitz RE, Malluche HH. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients. J Clin Endocrinol Metab. 1986 May; 62(5):869-73. PMID: 3485651.
    View in: PubMed
  135. Malluche HH, Faugere MC, Smith AJ, Friedler RM. Aluminum intoxication of bone in renal failure--fact or fiction? Kidney Int Suppl. 1986 Feb; 18:S70-3. PMID: 3458000.
    View in: PubMed
  136. Malluche HH, Faugère MC, Ritz E, Caillens G, Wildberger D. Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure. Miner Electrolyte Metab. 1986; 12(2):113-8. PMID: 3960014.
    View in: PubMed
  137. Faugere MC, Okamoto S, DeLuca HF, Malluche HH. Calcitriol corrects bone loss induced by oophorectomy in rats. Am J Physiol. 1986 Jan; 250(1 Pt 1):E35-8. PMID: 3753635.
    View in: PubMed
  138. Smith AJ, Faugère MC, Abreo K, Fanti P, Julian B, Malluche HH. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol. 1986; 6(4):275-83. PMID: 3777036.
    View in: PubMed
  139. Malluche HH, Matthews C, Faugere MC, Fanti P, Friedler RM. Parathyroid hormone and 1.25 vitamin D3 exert opposite effects on bone. Adv Exp Med Biol. 1986; 208:289-90. PMID: 3031941.
    View in: PubMed
  140. Malluche HH, Faugere MC. Aluminum: toxin or innocent bystander in renal osteodystrophy. Am J Kidney Dis. 1985 Nov; 6(5):336-41. PMID: 3904426.
    View in: PubMed
  141. Freundlich M, Zilleruelo G, Abitbol C, Strauss J, Faugere MC, Malluche HH. Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet. 1985 Sep 7; 2(8454):527-9. PMID: 2863545.
    View in: PubMed
  142. Ritz E, Bommer J, Malluche H. Bicarbonate dialysis--so what? Contrib Nephrol. 1985; 44:78-96. PMID: 3886285.
    View in: PubMed
  143. Malluche HH, Faugere MC, Fanti P, Price PA. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int. 1984 Dec; 26(6):869-74. PMID: 6335905.
    View in: PubMed
  144. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH. Iga nephropathy: presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis. 1984 Sep; 4(2):192-200. PMID: 6475950.
    View in: PubMed
  145. Malluche HH, Smith AJ, Abreo K, Faugere MC. The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure. N Engl J Med. 1984 Jul 19; 311(3):140-4. PMID: 6377067.
    View in: PubMed
  146. Dorr LD, Lindberg JP, Claude-Faugere M, Malluche HH. Factors influencing the intrusion of methylmethacrylate into human tibiae. Clin Orthop Relat Res. 1984 Mar; (183):147-52. PMID: 6697581.
    View in: PubMed
  147. Glassock RJ, Malluche HH, Tate M, Stelling CB, Smith AJ, Doukas M, Mitchell B. Recurrent fractures, hypophosphatemia, and renal insufficiency in an elderly woman. Am J Nephrol. 1984; 4(5):329-35. PMID: 6524603.
    View in: PubMed
  148. Faugere MC, Malluche HH. Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases. J Bone Joint Surg Am. 1983 Dec; 65(9):1314-8. PMID: 6361037.
    View in: PubMed
  149. Malluche HH, Meyer W, Sherman D, Massry SG. Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone. Calcif Tissue Int. 1982 Sep; 34(5):449-55. PMID: 6817892.
    View in: PubMed
  150. Malluche HH, Sherman D, Meyer W, Massry SG. A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int. 1982 Sep; 34(5):439-48. PMID: 6817891.
    View in: PubMed
  151. Malluche HH, Sherman D, Meyer W, Ritz E, Norman AW, Massry SG. Effects of long-term infusion of physiologic doses of 1-34 PTH on bone. Am J Physiol. 1982 Feb; 242(2):F197-201. PMID: 7065136.
    View in: PubMed
  152. Manaka RC, Malluche HH. A program package for quantitative analysis of histologic structure and remodeling dynamics of bone. Comput Programs Biomed. 1981 Sep-Dec; 13(3-4):191-201. PMID: 7032836.
    View in: PubMed
  153. Massry SG, Goldstein DA, Malluche HH. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy. Kidney Int. 1980 Oct; 18(4):409-18. PMID: 7014981.
    View in: PubMed
  154. Healy MD, Malluche HH, Goldstein DA, Singer FR, Massry SG. Effects of long-term therapy with calcitriol in patients with moderate renal failure. Arch Intern Med. 1980 Aug; 140(8):1030-3. PMID: 6893118.
    View in: PubMed
  155. Norman AW, Henry HL, Malluche HH. 24R,25-Dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 are both indispensable for calcium and phosphorus homeostasis. Life Sci. 1980 Jul 21; 27(3):229-37. PMID: 6967551.
    View in: PubMed
  156. Siede WH, Seiffert UB, Bundschuh F, Malluche HH, Schoeppe W. Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed renal osteopathy. Clin Nephrol. 1980 Jun; 13(6):277-81. PMID: 7408246.
    View in: PubMed
  157. Malluche HH, Henry H, Meyer-Sabellak W, Sherman D, Massry SG, Norman AW. Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone. Am J Physiol. 1980 May; 238(5):E494-8. PMID: 6246812.
    View in: PubMed
  158. Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980 Apr; 50(4):654-8. PMID: 6245099.
    View in: PubMed
  159. Malluche HH, Massry SG. The role of vitamin D metabolites in the management of bone abnormalities in renal disease. Adv Exp Med Biol. 1980; 128:615-24. PMID: 6999866.
    View in: PubMed
  160. Goldstein DA, Malluche HH, Massry SG. Long-term effects of 1,25(OH)2D3 on clinical and biochemical derangements of divalent ions in dialysis patients. Contrib Nephrol. 1980; 18:42-54. PMID: 7353379.
    View in: PubMed
  161. Malluche HH, Goldstein DA, Massry SG. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients. Contrib Nephrol. 1980; 18:98-104. PMID: 7353383.
    View in: PubMed
  162. Malluche HH, Goldstein DA, Massry SG. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome. J Clin Invest. 1979 Mar; 63(3):494-500. PMID: 429568.
    View in: PubMed
  163. Malluche HH, Ritz E, Werner E, Meyer-Sabellek WA. Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology. Clin Nephrol. 1978 Dec; 10(6):219-28. PMID: 215365.
    View in: PubMed
  164. Ritz E, Prager P, Krempien B, Bommer J, Malluche HH, Schmidt-Gayk H. Skeletal X-ray findings and bone histology in patients on hemodialysis. Kidney Int. 1978 Apr; 13(4):316-23. PMID: 651130.
    View in: PubMed
  165. Ritz E, Malluche HH, Krempien B, Tschope W, Massry SG. Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH. Adv Exp Med Biol. 1978; 103:423-36. PMID: 362849.
    View in: PubMed
  166. Werner E, Malluche HH, Ritz E. [Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC]. Verh Dtsch Ges Inn Med. 1977 Apr 17-21; 83:1305-7. PMID: 611840.
    View in: PubMed
  167. Malluche HH, Ritz E. [Experimental studies on parathyroid hormone resistance of the skeleton in kidney insufficiency]. Verh Dtsch Ges Inn Med. 1977 Apr 17-21; 83:1302-5. PMID: 611839.
    View in: PubMed
  168. Malluche HH, Ritz E, Lange HP, Schoeppe W. Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration. Clin Nephrol. 1976 Oct; 6(4):440-7. PMID: 975642.
    View in: PubMed
  169. Werner E, Malluche HH, Kutschera J, Hodgson M, Schoeppe W. Intestinal calcium absorption and whole-body calcium retention in various stages of renal insufficiency. Calcif Tissue Res. 1976 Aug; 21 Suppl:210-5. PMID: 953808.
    View in: PubMed
  170. Malluche HH, Ritz E, Lange HP, Arras D, Schoeppe W. Bone mass in maintenance haemodialysis. Prospective study with sequential biopsies. Eur J Clin Invest. 1976 Jul 30; 6(4):265-71. PMID: 954802.
    View in: PubMed
  171. Malluche HH, Ritz E, Lange HP, Kutschera L, Hodgson M, Seiffert U, Schoeppe W. Bone histology in incipient and advanced renal failure. Kidney Int. 1976 Apr; 9(4):355-62. PMID: 940274.
    View in: PubMed
  172. Malluche HH, Ritz E. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy]. MMW Munch Med Wochenschr. 1976 Jan 30; 118(5):129-30. PMID: 814442.
    View in: PubMed
  173. Malluche HH, Ritz E, Hodgson M, Kutschera J, Krause G, Seiffert U, Gati A, Lange HP. Skeletal lesions and calcium metabolism in early renal failure. Proc Eur Dial Transplant Assoc. 1975; 11:443-50. PMID: 1197269.
    View in: PubMed
  174. Malluche HH, Klempa I, Hodgson M, Feurle G, Koch KM. [Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and their modifications through changes in ionized serum calcium achieved by dialysis or parathyroidectomy]. MMW Munch Med Wochenschr. 1974 May 31; 116(22):1106. PMID: 4211644.
    View in: PubMed
  175. Andrassy K, Malluche H, Bornefeld H, Comberg M, Ritz E, Jesdinsky H, Möhring K. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr. 1974 Apr 1; 52(7):348-9. PMID: 4600820.
    View in: PubMed
  176. Klempa I, Malluche HH, Feurle G, Wünsch E. [Hypergastrinemia, hypercalcemia and stomach secretion (studies in chronic dialysis patients with secondary hyperparathyroidism before and after parathyroidectomy)]. Langenbecks Arch Chir. 1974; Suppl:101-5. PMID: 4464393.
    View in: PubMed
  177. Ritz E, Malluche H, Bommer J, Mehls O, Krempien B. Metabolic bone disease in patients on maintenance hemodialysis. Nephron. 1974; 12(5):393-404. PMID: 4832788.
    View in: PubMed
  178. Ritz E, Malluche H, Bommer J, Mehls O, Krempien B. Metabolic bone disease in patients on maintenance hemodialysis. Nephron. 1974; 12(5):393-404. PMID: 4824048.
    View in: PubMed
  179. Lange HP, Malluche HH, Arras D. [The renal osteodystrophy of bilateral nephrectomised patients with preoperative normal skeletal histology during chronic hemodialysis (author's transl)]. Verh Dtsch Ges Pathol. 1974; 58:366-70. PMID: 4218682.
    View in: PubMed
  180. Malluche HH, Klempa I, Hodgson M, Feurle G, Koch KM. [Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and its effect on them by changing ionized serum calcium]. Verh Dtsch Ges Inn Med. 1974; 80:690-2. PMID: 4217995.
    View in: PubMed
  181. Ritz E, Krempien B, Mehls O, Malluche H. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int. 1973 Aug; 4(2):116-27. PMID: 4790866.
    View in: PubMed
  182. Ritz E, Malluche HH, Röher HD, Krempien B, Koch KM, Andrassy K. [Some topical problems of subtotal parathyroidectomy in patients on haemodialysis]. Dtsch Med Wochenschr. 1973 Mar 9; 98(10):484-96. PMID: 4691570.
    View in: PubMed
  183. Fassbinder W, Reitinger W, Hügel E, Koch KM, Lange HP, Malluche HH, Schröder HM. [Conservative and surgical therapy of Goodpasture's syndrome]. Verh Dtsch Ges Inn Med. 1973; 79:703-5. PMID: 4789951.
    View in: PubMed
  184. Malluche HH, Ritz E, Koch KM, Krempien B, Schoeppe W. [Skeletal histology in uremic osteodystrophy following increase of dialysate calcium concentration to 3,75 mval-1 (preliminary report)]. Verh Dtsch Ges Inn Med. 1973; 79:729-31. PMID: 4789966.
    View in: PubMed
  185. MALLUCHE H. [The value of extrapleural pneumothorax within the framework of the current treatment of tuberculosis]. Poumon Coeur. 1961 Feb; 17:141-7. PMID: 13765886.
    View in: PubMed
  186. MALLUCHE H. [Extrapleural pneumolysis as the final step after the drainage of cavities]. Bruns Beitr Klin Chir. 1954 Nov; 189(3):299-305. PMID: 14351824.
    View in: PubMed
  187. MALLUCHE H. [Extrapleural pneumothorax as closure after cavitary drainage]. Schweiz Z Tuberk. 1954; 11(2):113-28. PMID: 13178655.
    View in: PubMed
  188. MALLUCHE H. [The value of tomography for the recognition of spinal tuberculosis]. Med Monatsschr. 1953 Oct; 7(10):660-1. PMID: 13132423.
    View in: PubMed
  189. MALLUCHE H. [Pneumolysis after drainage]. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1953; 109(2):163-71. PMID: 13093585.
    View in: PubMed
  190. MALLUCHE H. [Preliminary clinical results of the therapy of tuberculosis with isonicotinic acid hydrazide]. Med Klin (Munich). 1952 Jul 18; 17(29):961-4. PMID: 12982514.
    View in: PubMed
  191. MALLUCHE H. [Thiosemicarbazone therapy of tuberculosis]. Bibl Tuberc. 1952; 6:152-254. PMID: 13051393.
    View in: PubMed
  192. MALLUCHE H. [Clinical evaluation of tubersan]. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1951; 105(6):519-28. PMID: 14904356.
    View in: PubMed
  193. MALLUCHE H. [Combined intracavernous conteben (TB I) therapy]. Acta Med Scand. 1951; 139(2):105-21. PMID: 14810512.
    View in: PubMed
  194. MALLUCHE H. [Monaldi's cavern drainage combined with specific antituberculosis therapy]. Arch Tisiol Mal Appar Respir. 1950 Oct; 5(10):803-22. PMID: 14811718.
    View in: PubMed
  195. MALLUCHE H. [Exudate resorption property of thiosemicarbazone Tb 698]. Klin Wochenschr. 1950 Apr 1; 28(13-14):224-7. PMID: 15416014.
    View in: PubMed
  196. MALLUCHE H. [Not Available]. Med Monatsschr. 1949 Oct; 3(10):752-8. PMID: 15400713.
    View in: PubMed
  197. MALLUCHE H. [Not Available]. Med Klin. 1949 Feb 25; 44(8):225-31. PMID: 18126892.
    View in: PubMed
  198. MALLUCHE H. [Not Available]. Z Tuberk. 1949; 92(1-2):51-63. PMID: 18124482.
    View in: PubMed
  199. MALLUCHE H. [Not Available]. Med Klin. 1948 Sep; 43(18):509-12. PMID: 18102031.
    View in: PubMed
  200. MALLUCHE H. [Not Available]. Arztl Forsch. 1948 Jun 25; 2(11-12):197-200. PMID: 18881194.
    View in: PubMed
  201. MALLUCHE H. [Not Available]. Med Klin. 1948 Mar; 43(6):198-201. PMID: 18868248.
    View in: PubMed
  202. MALLUCHE H. [Not Available]. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1948; 101(4):330-48. PMID: 18889661.
    View in: PubMed
  203. MALLUCHE H. [Not Available]. Med Monatsschr. 1947 Dec; 1(12):535-7. PMID: 18902897.
    View in: PubMed
  204. MALLUCHE H. [Not Available]. Med Klin. 1947 Apr; 42(8):314-6. PMID: 18896126.
    View in: PubMed